<?xml version="1.0" encoding="UTF-8"?>
<p>Nevertheless, considering that RDV as well as its active metabolite are both ATP competitors, potential future side effects may emerge owing to the fact that multiple kinase (which all have ATP binding sites) functions could be altered by possible RDV inhibition.</p>
